Drug Development: Our portfolio of Tranlsational Platforms for Oncology and CVMD provide insight and understanding about a drug's efficacy, pharmacological profile and patient response profile, ...
enGene Inc. has developed a highly flexible nucleotide (DNA and RNAi) delivery technology that targets mucosal tissues and can be used to treat numerous prevalent, chronic diseases via the ...
The core goal of OneVax is to harness our knowledge of the immune system and biomaterials to create a tolerogenic vaccine to prevent and/or reverse type 1 diabetes.
